Distinguishing STAT3/STAT5B-mutated Large Granular Lymphocyte Leukemia from Myeloid Neoplasms by Genetic Profiling

Overview

Journal Blood Adv

Specialty Hematology

Date 2022 Aug 8

PMID 35939786

Authors

Mark Kavesh

Maedeh Mohebnasab

Marcela Riveros Angel

Wei Xie

Philipp W Raess

Wei Cui

Richard D Press

Guang Yang

Peng Li

Affiliations

Soon will be listed here.

Citing Articles

Unveiling myeloid transformation: T-LGLL with eosinophilia masking myeloid-associated STAT5B mutation culminating in AML.

Dong Q, Wang Y, Xiu Y, Wu X, ONeill S, Meyerson H Br J Haematol. 2024; 204(6):2487-2491.

PMID: 38508872 PMC: 11178439. DOI: 10.1111/bjh.19421.

Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell aplasia: low mutational burden of STAT3.

Park S, Yun J, Choi S, Jeong D, Gu J, Lee J Sci Rep. 2023; 13(1):7280.

PMID: 37142644 PMC: 10160083. DOI: 10.1038/s41598-023-33928-z.

References

Cross N, Hoade Y, Tapper W, Carreno-Tarragona G, Fanelli T, Jawhar M . Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia. Leukemia. 2018; 33(2):415-425. PMC: 6365490. DOI: 10.1038/s41375-018-0342-3. View

Jerez A, Clemente M, Makishima H, Koskela H, LeBlanc F, Ng K . STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood. 2012; 120(15):3048-57. PMC: 3471515. DOI: 10.1182/blood-2012-06-435297. View

Durrani J, Awada H, Kishtagari A, Visconte V, Kerr C, Adema V . Large granular lymphocytic leukemia coexists with myeloid clones and myelodysplastic syndrome. Leukemia. 2019; 34(3):957-962. PMC: 8370475. DOI: 10.1038/s41375-019-0601-y. View

Raess P, Cascio M, Fan G, Press R, Druker B, Brewer D . Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential. Am J Hematol. 2016; 92(1):E6-E8. DOI: 10.1002/ajh.24586. View

Polyatskin I, Artemyeva A, Krivolapov Y . [Revised WHO classification of tumors of hematopoietic and lymphoid tissues, 2017 (4th edition):lymphoid tumors]. Arkh Patol. 2019; 81(3):59-65. DOI: 10.17116/patol20198103159. View

Couronne L, Scourzic L, Pilati C, Valle V, Duffourd Y, Solary E . STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model. Haematologica. 2013; 98(11):1748-52. PMC: 3815176. DOI: 10.3324/haematol.2013.085068. View

Steensma D . Clinical consequences of clonal hematopoiesis of indeterminate potential. Blood Adv. 2018; 2(22):3404-3410. PMC: 6258914. DOI: 10.1182/bloodadvances.2018020222. View

Pandolfi F, Loughran Jr T, Starkebaum G, Chisesi T, Barbui T, Chan W . Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study. Cancer. 1990; 65(2):341-8. DOI: 10.1002/1097-0142(19900115)65:2<341::aid-cncr2820650227>3.0.co;2-2. View

Morice W, Kurtin P, Tefferi A, Hanson C . Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood. 2002; 99(1):268-74. DOI: 10.1182/blood.v99.1.268. View

10.

Qu S, Jia Y, Wang H, Ai X, Xu Z, Qin T . and mutations have unique distribution in T-cell large granular lymphocyte proliferations and advanced myeloid neoplasms. Leuk Lymphoma. 2021; 62(6):1506-1509. PMC: 9204507. DOI: 10.1080/10428194.2020.1869964. View

11.

Rajala H, Eldfors S, Kuusanmaki H, van Adrichem A, Olson T, Lagstrom S . Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. Blood. 2013; 121(22):4541-50. PMC: 3668487. DOI: 10.1182/blood-2012-12-474577. View

12.

Funakoshi-Tago M, Tago K, Abe M, Sonoda Y, Kasahara T . STAT5 activation is critical for the transformation mediated by myeloproliferative disorder-associated JAK2 V617F mutant. J Biol Chem. 2009; 285(8):5296-307. PMC: 2820758. DOI: 10.1074/jbc.M109.040733. View

13.

Lewis N, Petrova-Drus K, Huet S, Epstein-Peterson Z, Gao Q, Sigler A . Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms. Blood Adv. 2020; 4(10):2261-2271. PMC: 7252546. DOI: 10.1182/bloodadvances.2020001636. View

14.

Lundell R, Hartung L, Hill S, Perkins S, Bahler D . T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules. Am J Clin Pathol. 2006; 124(6):937-46. View

15.

Huh Y, Medeiros L, Ravandi F, Konoplev S, Jorgensen J, Miranda R . T-cell large granular lymphocyte leukemia associated with myelodysplastic syndrome: a clinicopathologic study of nine cases. Am J Clin Pathol. 2009; 131(3):347-56. DOI: 10.1309/AJCP6YHI1JEXAWAP. View

16.

Kim D, Park G, Huuhtanen J, Ghimire B, Rajala H, Moriggl R . STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation. Leukemia. 2021; 35(12):3430-3443. PMC: 8632689. DOI: 10.1038/s41375-021-01296-0. View

17.

Koskela H, Eldfors S, Ellonen P, van Adrichem A, Kuusanmaki H, Andersson E . Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med. 2012; 366(20):1905-13. PMC: 3693860. DOI: 10.1056/NEJMoa1114885. View

18.

Galli A, Todisco G, Catamo E, Sala C, Elena C, Pozzi S . Relationship between clone metrics and clinical outcome in clonal cytopenia. Blood. 2021; 138(11):965-976. DOI: 10.1182/blood.2021011323. View

19.

Saunthararajah Y, Molldrem J, Rivera M, Williams A, Stetler-Stevenson M, Sorbara L . Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features. Br J Haematol. 2001; 112(1):195-200. DOI: 10.1046/j.1365-2141.2001.02561.x. View

20.

Greenfield G, McMullin M, Mills K . Molecular pathogenesis of the myeloproliferative neoplasms. J Hematol Oncol. 2021; 14(1):103. PMC: 8246678. DOI: 10.1186/s13045-021-01116-z. View